![[ contact ]](../gifs/contactx.gif) |
About the Coinfection Project:
TAG closely monitors new data on the epidemiology and natural history of HIV/HCV coinfection and HIV/TB coinfection, as well as the development of new diagnostics, prophylaxis and treatments for hepatitis C and tuberculosis, in both the pre- and postmarketing stages. We advocate for the expeditious development, proper clinical research and regulation, ease of access and optimal use of these drugs. We work with the pharmaceutical companies, NIH, FDA, researchers and other treatment activists to achieve these objectives. TAG also educates members of the HIV community about coinfection with hepatitis C and tuberculosis. |